Louisiana State Employees Retirement System Eagle Pharmaceuticals, Inc. Transaction History

Louisiana State Employees Retirement System

$5.33 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$41.26 - $51.35 $4,126 - $5,135	-100 Reduced 1.82%	5,400 $235,000
Q4 2021 Jan 14, 2022	SELL	$45.82 - $56.9 $4,582 - $5,690	-100 Reduced 1.79%	5,500 $280,000
Q3 2021 Oct 12, 2021	BUY	$43.79 - $55.78 $13,137 - $16,734	300 Added 5.66%	5,600 $312,000
Q4 2020 Jan 11, 2021	SELL	$41.72 - $51.34 $12,516 - $15,402	-300 Reduced 5.36%	5,300 $247,000
Q3 2020 Oct 19, 2020	BUY	$37.02 - $51.28 $207,312 - $287,168	5,600 New	5,600 $238,000
Q1 2020 Apr 13, 2020	SELL	$34.37 - $60.07 $117,889 - $206,040	-3,430 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$54.32 - $64.31 $14,666 - $17,363	-270 Reduced 7.3%	3,430 $206,000
Q3 2019 Oct 24, 2019	SELL	$53.25 - $59.98 $5,325 - $5,998	-100 Reduced 2.63%	3,700 $209,000
Q2 2019 Jul 15, 2019	BUY	$46.61 - $58.45 $177,118 - $222,110	3,800 New	3,800 $206,000
Q4 2018 Jan 14, 2019	SELL	$36.72 - $67.73 $179,928 - $331,877	-4,900 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$66.65 - $83.86 $79,980 - $100,632	1,200 Added 32.43%	4,900 $340,000
Q2 2018 Jul 18, 2018	BUY	$51.25 - $76.62 $189,625 - $283,494	3,700 New	3,700 $280,000
Q4 2017 Jan 16, 2018	SELL	$49.6 - $60.87 $173,600 - $213,045	-3,500 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$46.62 - $60.36 $163,170 - $211,260	3,500	3,500 $209,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account